The impact of COVID-19 on stroke rehabilitation

Yasemin Tombak; Ebru Umay; Methiye Kübra Sezer; Özgür Zeliha Karaahmet; Ece Ünlü Akyüz; Aysegul Tombak; Eda Gürcay

Makale detayları

The impact of COVID-19 on stroke rehabilitation

Yazarlar:

Yasemin Tombak | Ebru Umay | Methiye Kübra Sezer | Özgür Zeliha Karaahmet | Ece Ünlü Akyüz | Aysegul Tombak | Eda Gürcay

Yayıncı:

Ondokuz Mayıs University

Ana Başlıklar:

Neurology and Neuromuscular Diseases

Dergi:

Deneysel ve Klinik Tıp Dergisi Vol.41 Issue 1, pp.97-101

Belge Tipi:

Makale

Yayın Tarihi:

3/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001314299

pISSN:

1309-4483

Anahtar kelimeler:

Özet:

 In literature, it has been suggested that SARS-CoV-2s impact on the heart and brain may contribute to immune-mediated thrombosis, the renin-angiotensin system related to the pathogenesis of ischemic stroke. Our study compares the rehabilitation outcomes of stroke patients with and without a history of COVID-19. Our study aims to compare rehabilitation results of COVID-19-associated ischemic stroke patients and non-COVID-19 patients, as thrombotic complications and ischemic stroke have largely been reported since the pandemics beginning. This study included 83 stroke patients aged 18-80 years who were hospitalized and rehabilitated. Patients age, gender, lesion location, Brunnstrom stage, ambulation level, comorbidities, Charlson comorbidity index, stroke type, pre-stroke history of COVID-19 and symptoms, previous stroke history, and duration of physical therapy program were recorded. Those with a history of COVID-19 reverse transcriptase polymerase chain reaction test being positive andor a history of pneumonia compatible with COVID-19 on thoracic computed tomography examination 28 patients were included in the COVID-19 group while those without those conditions were included in the non-COVID-19 group 55 patients. Factors contributing to rehabilitation results were compared between the groups. The rehabilitation outcomes were similar across the groups, with no differences in ambulation levels or Brunnstrom staging hand, upper and lower extremities p values 0.237, 0.155, 0.380, 0.192, respectively. However, the COVID-19 group had higher rates of ischemic heart disease and hypothyroidism, no prior history of cerebrovascular accident, more periventricular infarctions, and initially more adversely affected ambulation levels p values 0.047, 0.038, 0.042, 0.037, 0.028, respectively. The study concluded that there was no apparent difference between the two groups outcome parameters. Although the COVID-19 groups ambulation level was initially more negatively impacted, no detrimental effects on rehabilitation outcomes were found.

 In literature, it has been suggested that SARS-CoV-2s impact on the heart and brain may contribute to immune-mediated thrombosis, the renin-angiotensin system related to the pathogenesis of ischemic stroke. Our study compares the rehabilitation outcomes of stroke patients with and without a history of COVID-19. Our study aims to compare rehabilitation results of COVID-19-associated ischemic stroke patients and non-COVID-19 patients, as thrombotic complications and ischemic stroke have largely been reported since the pandemics beginning. This study included 83 stroke patients aged 18-80 years who were hospitalized and rehabilitated. Patients age, gender, lesion location, Brunnstrom stage, ambulation level, comorbidities, Charlson comorbidity index, stroke type, pre-stroke history of COVID-19 and symptoms, previous stroke history, and duration of physical therapy program were recorded. Those with a history of COVID-19 reverse transcriptase polymerase chain reaction test being positive andor a history of pneumonia compatible with COVID-19 on thoracic computed tomography examination 28 patients were included in the COVID-19 group while those without those conditions were included in the non-COVID-19 group 55 patients. Factors contributing to rehabilitation results were compared between the groups. The rehabilitation outcomes were similar across the groups, with no differences in ambulation levels or Brunnstrom staging hand, upper and lower extremities p values 0.237, 0.155, 0.380, 0.192, respectively. However, the COVID-19 group had higher rates of ischemic heart disease and hypothyroidism, no prior history of cerebrovascular accident, more periventricular infarctions, and initially more adversely affected ambulation levels p values 0.047, 0.038, 0.042, 0.037, 0.028, respectively. The study concluded that there was no apparent difference between the two groups outcome parameters. Although the COVID-19 groups ambulation level was initially more negatively impacted, no detrimental effects on rehabilitation outcomes were found.

 In literature, it has been suggested that SARS-CoV-2s impact on the heart and brain may contribute to immune-mediated thrombosis, the renin-angiotensin system related to the pathogenesis of ischemic stroke. Our study compares the rehabilitation outcomes of stroke patients with and without a history of COVID-19. Our study aims to compare rehabilitation results of COVID-19-associated ischemic stroke patients and non-COVID-19 patients, as thrombotic complications and ischemic stroke have largely been reported since the pandemics beginning. This study included 83 stroke patients aged 18-80 years who were hospitalized and rehabilitated. Patients age, gender, lesion location, Brunnstrom stage, ambulation level, comorbidities, Charlson comorbidity index, stroke type, pre-stroke history of COVID-19 and symptoms, previous stroke history, and duration of physical therapy program were recorded. Those with a history of COVID-19 reverse transcriptase polymerase chain reaction test being positive andor a history of pneumonia compatible with COVID-19 on thoracic computed tomography examination 28 patients were included in the COVID-19 group while those without those conditions were included in the non-COVID-19 group 55 patients. Factors contributing to rehabilitation results were compared between the groups. The rehabilitation outcomes were similar across the groups, with no differences in ambulation levels or Brunnstrom staging hand, upper and lower extremities p values 0.237, 0.155, 0.380, 0.192, respectively. However, the COVID-19 group had higher rates of ischemic heart disease and hypothyroidism, no prior history of cerebrovascular accident, more periventricular infarctions, and initially more adversely affected ambulation levels p values 0.047, 0.038, 0.042, 0.037, 0.028, respectively. The study concluded that there was no apparent difference between the two groups outcome parameters. Although the COVID-19 groups ambulation level was initially more negatively impacted, no detrimental effects on rehabilitation outcomes were found.

 In literature, it has been suggested that SARS-CoV-2s impact on the heart and brain may contribute to immune-mediated thrombosis, the renin-angiotensin system related to the pathogenesis of ischemic stroke. Our study compares the rehabilitation outcomes of stroke patients with and without a history of COVID-19. Our study aims to compare rehabilitation results of COVID-19-associated ischemic stroke patients and non-COVID-19 patients, as thrombotic complications and ischemic stroke have largely been reported since the pandemics beginning. This study included 83 stroke patients aged 18-80 years who were hospitalized and rehabilitated. Patients age, gender, lesion location, Brunnstrom stage, ambulation level, comorbidities, Charlson comorbidity index, stroke type, pre-stroke history of COVID-19 and symptoms, previous stroke history, and duration of physical therapy program were recorded. Those with a history of COVID-19 reverse transcriptase polymerase chain reaction test being positive andor a history of pneumonia compatible with COVID-19 on thoracic computed tomography examination 28 patients were included in the COVID-19 group while those without those conditions were included in the non-COVID-19 group 55 patients. Factors contributing to rehabilitation results were compared between the groups. The rehabilitation outcomes were similar across the groups, with no differences in ambulation levels or Brunnstrom staging hand, upper and lower extremities p values 0.237, 0.155, 0.380, 0.192, respectively. However, the COVID-19 group had higher rates of ischemic heart disease and hypothyroidism, no prior history of cerebrovascular accident, more periventricular infarctions, and initially more adversely affected ambulation levels p values 0.047, 0.038, 0.042, 0.037, 0.028, respectively. The study concluded that there was no apparent difference between the two groups outcome parameters. Although the COVID-19 groups ambulation level was initially more negatively impacted, no detrimental effects on rehabilitation outcomes were found.

Makale detayları

The impact of COVID-19 on stroke rehabilitation

Yazarlar: Yasemin Tombak | Ebru Umay | Methiye Kübra Sezer | Özgür Zeliha Karaahmet | Ece Ünlü Akyüz | Aysegul Tombak | Eda Gürcay

Yayıncı: Ondokuz Mayıs University

Ana Başlıklar: Neurology and Neuromuscular Diseases

Dergi: Deneysel ve Klinik Tıp Dergisi Vol.41 Issue 1, pp.97-101

Belge Tipi: Makale

Yayın Tarihi: 3/2024

Belge Dili: İngilizce

Document ID (Org No.): 2001314299

pISSN: 1309-4483

cerebrovascular accident

COVID-19

ischemic heart disease

rehabilitation

stroke

Sayı

Yazarlar:

Yasemin Tombak | Ebru Umay | Methiye Kübra Sezer | Özgür Zeliha Karaahmet | Ece Ünlü Akyüz | Aysegul Tombak | Eda Gürcay

Yayıncı:

Ondokuz Mayıs University

Ana Başlıklar:

Neurology and Neuromuscular Diseases

Dergi:

Deneysel ve Klinik Tıp Dergisi Vol.41 Issue 1, pp.97-101

Belge Tipi:

Makale

Yayın Tarihi:

3/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001314299

pISSN:

1309-4483